Page 29 - Central Drug Authority Annual Report 2021

7. REPORTS AND REPORTING

$V LQGLFDWHG HDUOLHU WKH &'$ LV UHTXLUHG WR VXEPLW DQ $QQXDO ,Q DGGLWLRQ DQ ,QWHU 0LQLVWHULDO &RPPLWWHH ,0& ZDV
5HSRUW WR FDELQHW E\ WKH 6HSWHPEHU LQ WHUPV RI $FW RI FUHDWHG WR JLYH SROLF\ GLUHFWLYHV DQG FR RUGLQDWH DFWLYLWLHV LQ
7KH FXUUHQW &'$ KDV VXEPLWWHG DOO UHSRUWV LQFOXGLQJ UHODWLRQ WR VXEVWDQFH XVH LQWHUYHQWLRQV 7KH ,0& LQFOXGHG
7KH GHOD\V LQ VXEPLWWLQJ UHSRUWV WR 3DUOLDPHQW 6RFLDO 'HYHORSPHQW -XVWLFH +HDOWK DQG (GXFDWLRQ %DVLF
ZHUH PRVWO\ FDXVHG E\ LQWHUQDO GHSDUWPHQWDO SURFHVVHV DQG +LJKHU 7KH &'$ ZDV UHSUHVHQWHG RQ WKLV ERG\ E\ WKH
Chairperson of the CDA.
$V SDUW RI WKH PRQLWRULQJ DQG HYDOXDWLRQ SURFHVV HDFK
GHSDUWPHQW DQG SURYLQFH LV UHTXLUHG WR VXEPLW D TXDUWHUO\ 7KH ,0& KDV FHDVHG WR IXQFWLRQ EXW ZDV NH\ LQ WKH DSSURYDO
UHSRUW WR WKH &'$ LQGLFDWLQJ WKHLU SURJUHVV LQ DFKLHYLQJ WKH DQG UHVRXUFLQJ RI FHUWDLQ SURJUDPPHV DV ZDV WKH FDVH ZLWK
WDUJHWV VHW LQ WKHLU UHVSHFWLYH 'UXJ 0DVWHU 3ODQV 6RPH DSSURYDO DQG IXQGLQJ E\ &DELQHW RI D VKRUW WHUP 3ODQ RI
VXFFHVV KDV EHHQ DFKLHYHG LQ WKLV ZD\ DOWKRXJK QRW DOO $FWLRQ DULVLQJ IURP WKH UHVROXWLRQV RI WKH QG %LHQQLDO
GHSDUWPHQWV DQG SURYLQFHV KDYH VXEPLWWHG UHSRUWV $QWL VXEVWDQFH $EXVH 6XPPLW RI 0DUFK
WLPHRXVO\ RU LQGHHG VXEPLWWHG WKHP DW DOO
0HHWLQJV RI WKH &'$ KDYH QRW EHHQ FRQVLVWHQW DV UHTXLUHG E\
7KH &'$ PXVW UHSRUW WR GHVLJQDWHG QDWLRQDO UHJLRQDO DQG WKH $FW RI GXH WR VHYHUDO UHDVRQV ZKLFK LQFOXGH
LQWHUQDWLRQDO VWUXFWXUHV LQ OLQH ZLWK OHJLVODWLYH PDQGDWHV DV FRPSHWLQJ LQWHUHVWV ZLWK UHJDUGV WR DYDLODELOLW\ DQG VXSSRUW
ZHOO DV FRQYHQWLRQV WKDW 6RXWK $IULFD LV D VLJQDWRU\ WR 6XFK IURP WKH 'HSDUWPHQW RI 6RFLDO 'HYHORSPHQW
VWUXFWXUHV LQFOXGH WKH )RUXP IRU 6RXWK $IULFDQ 'LUHFWRUV
*HQHUDO )26$' 3DUOLDPHQW &DELQHW 7KH $IULFDQ 8QLRQ
DQG 81 $JHQFLHV LQFOXGLQJ 81 2IˉFH RQ 'UXJV DQG &ULPH 6$
812'& &RPPLVVLRQ RQ 1DUFRWLF 'UXJV DQG ,QWHUQDWLRQDO
1DUFRWLF &RQWURO %RDUG

8. COMMITTEE MEETINGS 2020/21

7KHUH ZHUH WZR H[HFXWLYH FRPPLWWHH PHHWLQJV DQG WZR 7KLV KDG D GHOHWHULRXV HIIHFW RQ WKH HIIHFWLYHQHVV RI WKH &'$
H[WHQGHG JHQHUDO PHHWLQJV DW TXDUWHUO\ LQWHUYDOV WR ZKLFK DQG D TXRUXP ZDV RIWHQ QRW PHW LQ JHQHUDO PHHWLQJV
UHSUHVHQWDWLYHV RI WKH 3URYLQFLDO 6XEVWDQFH $EXVH )RUXPV 'LIˉFXOW\ ZDV DOVR H[SHULHQFHG LQ DUUDQJLQJ DQG KROGLQJ
ZHUH LQYLWHG PHHWLQJV ZLWK WKH 0LQLVWHU WR FRPSO\ ZLWK WKH $FW ZKLFK
UHTXLUHV WKH &'$ WR DGYLVH WKH 0LQLVWHU
7KH PDMRULW\ RI WKHVH PHHWLQJV ZHUH VSRUDGLF DQG
UHSUHVHQWDWLRQ E\ GHSDUWPHQWDO DSSRLQWHHV OLPLWHG 2IWHQ
GHSDUWPHQWV VHQW DOWHUQDWHV WR DWWHQG PHHWLQJV

Annual Report 2020/2021 Central Drug Authority 27